Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q14508: Variant p.Cys49Arg

WAP four-disulfide core domain protein 2
Gene: WFDC2
Feedback?
Variant information Variant position: help 49 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Cysteine (C) to Arginine (R) at position 49 (C49R, p.Cys49Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (C) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In BENP; likely pathogenic. Any additional useful information about the variant.


Sequence information Variant position: help 49 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 124 The length of the canonical sequence.
Location on the sequence: help GAEKTGVCPELQADQNCTQE C VSDSECADNLKCCSAGCATF The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         GAEKTGVCPELQADQNCTQECVSDSECADNLKCCSAGCATF

                              EVEKTGVCPQLQADLNCTQECVSDAQCADNLKCCQAGCATI

Mouse                         DAEKPGECPQLEPITDCVLECTLDKDCADNRKCCQAGCSSV

Rat                           RAEKPGVCPQLEPITDCVKACILDNDCQDNYKCCQAGCGSV

Pig                           GAEKSGVCPAVEVDMNCTQECLSDADCADNLKCCKAGCVTI

Rabbit                        GADKPGVCPQLSADLNCTQDCRADQDCAENLKCCRAGCSAI
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 31 – 124 WAP four-disulfide core domain protein 2
Domain 31 – 73 WAP 1
Glycosylation 44 – 44 N-linked (GlcNAc...) asparagine
Disulfide bond 36 – 62
Disulfide bond 45 – 66
Disulfide bond 49 – 61
Alternative sequence 24 – 74 Missing. In isoform 2.
Alternative sequence 27 – 74 Missing. In isoform 3.



Literature citations
Recessively inherited deficiency of secreted WFDC2 (HE4) causes nasal polyposis and bronchiectasis.
Dougherty G.W.; Ostrowski L.E.; Noethe-Menchen T.; Raidt J.; Schramm A.; Olbrich H.; Yin W.; Sears P.R.; Dang H.; Smith A.J.; Beule A.G.; Hjeij R.; Rutjes N.; Haarman E.G.; Maas S.M.; Ferkol T.W.; Noone P.G.; Olivier K.N.; Bracht D.C.; Barbry P.; Zaragosi L.E.; Fierville M.; Kliesch S.; Wohlgemuth K.; Koenig J.; George S.; Loges N.T.; Ceppe A.; Markovetz M.R.; Luo H.; Guo T.; Rizk H.; Eldesoky T.; Dahlke K.; Boldt K.; Ueffing M.; Hill D.B.; Pang Y.P.; Knowles M.R.; Zariwala M.A.; Omran H.;
Am. J. Respir. Crit. Care Med. 210:63-76(2024)
Cited for: VARIANTS BENP ARG-49; SER-91; ARG-103 AND TYR-109; INVOLVEMENT IN BENP;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.